# PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain

> **NCT03375515** · PHASE3 · COMPLETED · sponsor: **Fujian Cancer Hospital** · enrollment: 214 (actual)

## Conditions studied

- Cancer Pain

## Interventions

- **DRUG:** Hydromorphone
- **DEVICE:** PCA pump

## Key facts

- **NCT ID:** NCT03375515
- **Lead sponsor:** Fujian Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-29
- **Primary completion:** 2019-12-10
- **Final completion:** 2020-01-10
- **Target enrollment:** 214 (ACTUAL)
- **Last updated:** 2021-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03375515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03375515, "PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03375515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*